Healing CREI

Orphan and rare diseases drug company Lobe Sciences Ltd. (OTCQB: LOBEF) is set to acquire Altemia & Company LLC. The deal includes all Altemnia assets, intellectual property, and commercial inventory to manage patients suffering from Sickle Cell Disease (SCD), a group of hereditary red blood...

“Investing in real estate can help expand experiential medicines like ketamine and MDMA for treating PTSD and build infrastructure for upcoming FDA-approved therapies,” said Daniel Carcillo, founder and CEO at Wesana Health Holdings Inc (OTCQB: WSNAF) at Benzinga Psychedelics...